Screener
Intellia Therapeutics NTLA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's enterprise value?
- Intellia Therapeutics (NTLA) reported enterprise value of $2.33B in Q2 2026.
- How has Intellia Therapeutics's enterprise value changed year-over-year?
- Intellia Therapeutics's enterprise value increased by 148.6% year-over-year, from $937.71M to $2.33B.
- What is the long-term trend for Intellia Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), Intellia Therapeutics's enterprise value has grown at a -24.3% compound annual growth rate (CAGR), from $3.93B to $979.18M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Intellia Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude